nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—SLCO4C1—Methotrexate—bone cancer	0.244	0.319	CbGbCtD
Liotrix—SLCO1C1—Methotrexate—bone cancer	0.171	0.224	CbGbCtD
Liotrix—SLCO1B3—Methotrexate—bone cancer	0.0955	0.125	CbGbCtD
Liotrix—SLCO1A2—Methotrexate—bone cancer	0.059	0.0772	CbGbCtD
Liotrix—SLCO1B1—Methotrexate—bone cancer	0.0556	0.0729	CbGbCtD
Liotrix—SLC22A8—Methotrexate—bone cancer	0.0513	0.0673	CbGbCtD
Liotrix—ALB—Methotrexate—bone cancer	0.0305	0.0399	CbGbCtD
Liotrix—ABCB1—Cisplatin—bone cancer	0.0245	0.0322	CbGbCtD
Liotrix—ABCB1—Doxorubicin—bone cancer	0.0164	0.0215	CbGbCtD
Liotrix—ABCB1—Methotrexate—bone cancer	0.0159	0.0209	CbGbCtD
Liotrix—SERPINA7—vertebral column—bone cancer	0.00707	0.36	CbGeAlD
Liotrix—SLC10A1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00406	0.0702	CbGpPWpGaD
Liotrix—TTR—vertebral column—bone cancer	0.00325	0.165	CbGeAlD
Liotrix—THRB—Nuclear Receptors—NR1I2—bone cancer	0.00303	0.0524	CbGpPWpGaD
Liotrix—THRA—Nuclear Receptors—NR1I2—bone cancer	0.00303	0.0524	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—FEV—bone cancer	0.00289	0.05	CbGpPWpGaD
Liotrix—THRB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00239	0.0414	CbGpPWpGaD
Liotrix—THRA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00239	0.0414	CbGpPWpGaD
Liotrix—SLC10A1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00237	0.041	CbGpPWpGaD
Liotrix—SLC10A1—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00217	0.0375	CbGpPWpGaD
Liotrix—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00183	0.0315	CbGpPWpGaD
Liotrix—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00171	0.0295	CbGpPWpGaD
Liotrix—THRA—Generic Transcription Pathway—ZNF77—bone cancer	0.00122	0.0211	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—ZNF77—bone cancer	0.00122	0.0211	CbGpPWpGaD
Liotrix—SLCO1B1—Irinotecan Pathway—CYP3A4—bone cancer	0.00117	0.0202	CbGpPWpGaD
Liotrix—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00104	0.018	CbGpPWpGaD
Liotrix—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000999	0.0173	CbGpPWpGaD
Liotrix—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000998	0.0173	CbGpPWpGaD
Liotrix—SERPINA7—bone marrow—bone cancer	0.00099	0.0505	CbGeAlD
Liotrix—SERPINA7—spinal cord—bone cancer	0.000986	0.0502	CbGeAlD
Liotrix—THRA—Endochondral Ossification—IGF1R—bone cancer	0.000939	0.0162	CbGpPWpGaD
Liotrix—THRA—connective tissue—bone cancer	0.000919	0.0468	CbGeAlD
Liotrix—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000914	0.0158	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—PLOD2—bone cancer	0.000872	0.0151	CbGpPWpGaD
Liotrix—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000856	0.0148	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000854	0.0148	CbGpPWpGaD
Liotrix—Necrosis—Methotrexate—bone cancer	0.000842	0.00531	CcSEcCtD
Liotrix—Abscess—Methotrexate—bone cancer	0.000835	0.00527	CcSEcCtD
Liotrix—Irritability—Cisplatin—bone cancer	0.000835	0.00527	CcSEcCtD
Liotrix—ALB—Folate Metabolism—FOLR1—bone cancer	0.000829	0.0143	CbGpPWpGaD
Liotrix—Blood creatinine increased—Cisplatin—bone cancer	0.000819	0.00517	CcSEcCtD
Liotrix—Dehydration—Cisplatin—bone cancer	0.000813	0.00513	CcSEcCtD
Liotrix—Hypokalaemia—Cisplatin—bone cancer	0.000796	0.00502	CcSEcCtD
Liotrix—Necrosis—Epirubicin—bone cancer	0.000788	0.00497	CcSEcCtD
Liotrix—Feeling hot—Epirubicin—bone cancer	0.000788	0.00497	CcSEcCtD
Liotrix—Abscess—Epirubicin—bone cancer	0.000782	0.00493	CcSEcCtD
Liotrix—THRA—Endochondral Ossification—PLAU—bone cancer	0.000765	0.0132	CbGpPWpGaD
Liotrix—Extravasation—Methotrexate—bone cancer	0.000758	0.00478	CcSEcCtD
Liotrix—Sweating increased—Cisplatin—bone cancer	0.000736	0.00465	CcSEcCtD
Liotrix—Necrosis—Doxorubicin—bone cancer	0.000729	0.0046	CcSEcCtD
Liotrix—Feeling hot—Doxorubicin—bone cancer	0.000729	0.0046	CcSEcCtD
Liotrix—Levothyroxine—CYP3A4—bone cancer	0.000727	1	CrCbGaD
Liotrix—Abscess—Doxorubicin—bone cancer	0.000723	0.00456	CcSEcCtD
Liotrix—Oliguria—Methotrexate—bone cancer	0.000717	0.00453	CcSEcCtD
Liotrix—Extravasation—Epirubicin—bone cancer	0.000709	0.00447	CcSEcCtD
Liotrix—Ulcer—Methotrexate—bone cancer	0.000699	0.00441	CcSEcCtD
Liotrix—TTR—connective tissue—bone cancer	0.000683	0.0348	CbGeAlD
Liotrix—Cellulitis—Epirubicin—bone cancer	0.00068	0.00429	CcSEcCtD
Liotrix—Hypocalcaemia—Epirubicin—bone cancer	0.000676	0.00426	CcSEcCtD
Liotrix—Oliguria—Epirubicin—bone cancer	0.000671	0.00424	CcSEcCtD
Liotrix—Acute coronary syndrome—Cisplatin—bone cancer	0.000664	0.00419	CcSEcCtD
Liotrix—Renal failure—Cisplatin—bone cancer	0.000662	0.00418	CcSEcCtD
Liotrix—Myocardial infarction—Cisplatin—bone cancer	0.00066	0.00417	CcSEcCtD
Liotrix—Extravasation—Doxorubicin—bone cancer	0.000656	0.00414	CcSEcCtD
Liotrix—Ulcer—Epirubicin—bone cancer	0.000654	0.00413	CcSEcCtD
Liotrix—Creatinine increased—Epirubicin—bone cancer	0.00065	0.0041	CcSEcCtD
Liotrix—SLCO4C1—bone marrow—bone cancer	0.000638	0.0325	CbGeAlD
Liotrix—THRB—tendon—bone cancer	0.000632	0.0322	CbGeAlD
Liotrix—THRA—tendon—bone cancer	0.000632	0.0322	CbGeAlD
Liotrix—Cellulitis—Doxorubicin—bone cancer	0.000629	0.00397	CcSEcCtD
Liotrix—Hypocalcaemia—Doxorubicin—bone cancer	0.000625	0.00395	CcSEcCtD
Liotrix—Oliguria—Doxorubicin—bone cancer	0.000621	0.00392	CcSEcCtD
Liotrix—THRA—spinal cord—bone cancer	0.000609	0.031	CbGeAlD
Liotrix—Ulcer—Doxorubicin—bone cancer	0.000605	0.00382	CcSEcCtD
Liotrix—Coma—Methotrexate—bone cancer	0.000604	0.00381	CcSEcCtD
Liotrix—Creatinine increased—Doxorubicin—bone cancer	0.000601	0.00379	CcSEcCtD
Liotrix—THRA—Gene Expression—ZNF77—bone cancer	0.000588	0.0102	CbGpPWpGaD
Liotrix—THRB—Gene Expression—ZNF77—bone cancer	0.000588	0.0102	CbGpPWpGaD
Liotrix—Fluid retention—Epirubicin—bone cancer	0.000587	0.00371	CcSEcCtD
Liotrix—Blood urea increased—Epirubicin—bone cancer	0.000584	0.00369	CcSEcCtD
Liotrix—Sepsis—Methotrexate—bone cancer	0.000574	0.00362	CcSEcCtD
Liotrix—Coma—Epirubicin—bone cancer	0.000565	0.00357	CcSEcCtD
Liotrix—Flushing—Cisplatin—bone cancer	0.000561	0.00354	CcSEcCtD
Liotrix—SLC16A2—spinal cord—bone cancer	0.000552	0.0281	CbGeAlD
Liotrix—Fluid retention—Doxorubicin—bone cancer	0.000543	0.00343	CcSEcCtD
Liotrix—Arrhythmia—Cisplatin—bone cancer	0.00054	0.00341	CcSEcCtD
Liotrix—Blood urea increased—Doxorubicin—bone cancer	0.00054	0.00341	CcSEcCtD
Liotrix—Sepsis—Epirubicin—bone cancer	0.000537	0.00339	CcSEcCtD
Liotrix—Alopecia—Cisplatin—bone cancer	0.000535	0.00337	CcSEcCtD
Liotrix—Coma—Doxorubicin—bone cancer	0.000523	0.0033	CcSEcCtD
Liotrix—Phlebitis—Epirubicin—bone cancer	0.000521	0.00329	CcSEcCtD
Liotrix—Renal failure acute—Methotrexate—bone cancer	0.00052	0.00328	CcSEcCtD
Liotrix—Flatulence—Cisplatin—bone cancer	0.000519	0.00327	CcSEcCtD
Liotrix—SLCO1C1—spinal cord—bone cancer	0.000506	0.0258	CbGeAlD
Liotrix—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000504	0.00871	CbGpPWpGaD
Liotrix—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.0005	0.00864	CbGpPWpGaD
Liotrix—Sepsis—Doxorubicin—bone cancer	0.000497	0.00313	CcSEcCtD
Liotrix—Vision blurred—Cisplatin—bone cancer	0.000496	0.00313	CcSEcCtD
Liotrix—Cardiac failure congestive—Epirubicin—bone cancer	0.000495	0.00312	CcSEcCtD
Liotrix—Tremor—Cisplatin—bone cancer	0.000493	0.00311	CcSEcCtD
Liotrix—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000492	0.0085	CbGpPWpGaD
Liotrix—Cerebrovascular accident—Methotrexate—bone cancer	0.00049	0.00309	CcSEcCtD
Liotrix—Renal failure acute—Epirubicin—bone cancer	0.000486	0.00307	CcSEcCtD
Liotrix—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000485	0.00838	CbGpPWpGaD
Liotrix—Phlebitis—Doxorubicin—bone cancer	0.000482	0.00304	CcSEcCtD
Liotrix—Increased appetite—Epirubicin—bone cancer	0.000478	0.00302	CcSEcCtD
Liotrix—Renal impairment—Epirubicin—bone cancer	0.000472	0.00298	CcSEcCtD
Liotrix—Hypoglycaemia—Epirubicin—bone cancer	0.00046	0.0029	CcSEcCtD
Liotrix—Cardiac failure—Epirubicin—bone cancer	0.00046	0.0029	CcSEcCtD
Liotrix—Cerebrovascular accident—Epirubicin—bone cancer	0.000458	0.00289	CcSEcCtD
Liotrix—Cardiac failure congestive—Doxorubicin—bone cancer	0.000458	0.00289	CcSEcCtD
Liotrix—Irritability—Methotrexate—bone cancer	0.000458	0.00289	CcSEcCtD
Liotrix—Convulsion—Cisplatin—bone cancer	0.000456	0.00288	CcSEcCtD
Liotrix—TTR—bone marrow—bone cancer	0.000455	0.0232	CbGeAlD
Liotrix—Mood swings—Methotrexate—bone cancer	0.000455	0.00287	CcSEcCtD
Liotrix—THRA—Endochondral Ossification—MMP9—bone cancer	0.000453	0.00784	CbGpPWpGaD
Liotrix—TTR—spinal cord—bone cancer	0.000453	0.0231	CbGeAlD
Liotrix—Renal failure acute—Doxorubicin—bone cancer	0.00045	0.00284	CcSEcCtD
Liotrix—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000449	0.00777	CbGpPWpGaD
Liotrix—Anxiety—Cisplatin—bone cancer	0.000447	0.00282	CcSEcCtD
Liotrix—Increased appetite—Doxorubicin—bone cancer	0.000442	0.00279	CcSEcCtD
Liotrix—Affect lability—Epirubicin—bone cancer	0.000442	0.00279	CcSEcCtD
Liotrix—Renal impairment—Doxorubicin—bone cancer	0.000437	0.00275	CcSEcCtD
Liotrix—TTR—Extracellular matrix organization—LOX—bone cancer	0.000431	0.00744	CbGpPWpGaD
Liotrix—Anaphylactic shock—Cisplatin—bone cancer	0.00043	0.00271	CcSEcCtD
Liotrix—Oedema—Cisplatin—bone cancer	0.00043	0.00271	CcSEcCtD
Liotrix—Cardiac arrest—Epirubicin—bone cancer	0.000427	0.00269	CcSEcCtD
Liotrix—Infection—Cisplatin—bone cancer	0.000427	0.00269	CcSEcCtD
Liotrix—Hypoglycaemia—Doxorubicin—bone cancer	0.000426	0.00269	CcSEcCtD
Liotrix—Cardiac failure—Doxorubicin—bone cancer	0.000426	0.00269	CcSEcCtD
Liotrix—Mood swings—Epirubicin—bone cancer	0.000425	0.00268	CcSEcCtD
Liotrix—Cerebrovascular accident—Doxorubicin—bone cancer	0.000424	0.00268	CcSEcCtD
Liotrix—Blood creatinine increased—Epirubicin—bone cancer	0.000421	0.00265	CcSEcCtD
Liotrix—Tachycardia—Cisplatin—bone cancer	0.000419	0.00265	CcSEcCtD
Liotrix—Dehydration—Epirubicin—bone cancer	0.000418	0.00264	CcSEcCtD
Liotrix—Hyperhidrosis—Cisplatin—bone cancer	0.000415	0.00262	CcSEcCtD
Liotrix—THRA—Generic Transcription Pathway—NR1I2—bone cancer	0.000414	0.00715	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—NR1I2—bone cancer	0.000414	0.00715	CbGpPWpGaD
Liotrix—Anorexia—Cisplatin—bone cancer	0.00041	0.00258	CcSEcCtD
Liotrix—Affect lability—Doxorubicin—bone cancer	0.000409	0.00258	CcSEcCtD
Liotrix—Hypokalaemia—Epirubicin—bone cancer	0.000409	0.00258	CcSEcCtD
Liotrix—SLCO4A1—spinal cord—bone cancer	0.000406	0.0207	CbGeAlD
Liotrix—Hypotension—Cisplatin—bone cancer	0.000402	0.00253	CcSEcCtD
Liotrix—Muscular weakness—Epirubicin—bone cancer	0.000396	0.0025	CcSEcCtD
Liotrix—Cardiac arrest—Doxorubicin—bone cancer	0.000395	0.00249	CcSEcCtD
Liotrix—Mood swings—Doxorubicin—bone cancer	0.000394	0.00248	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000392	0.00247	CcSEcCtD
Liotrix—Abdominal distension—Epirubicin—bone cancer	0.000391	0.00247	CcSEcCtD
Liotrix—Blood creatinine increased—Doxorubicin—bone cancer	0.000389	0.00246	CcSEcCtD
Liotrix—Dysphagia—Epirubicin—bone cancer	0.000388	0.00245	CcSEcCtD
Liotrix—Dehydration—Doxorubicin—bone cancer	0.000386	0.00244	CcSEcCtD
Liotrix—Paraesthesia—Cisplatin—bone cancer	0.000386	0.00244	CcSEcCtD
Liotrix—Dyspnoea—Cisplatin—bone cancer	0.000383	0.00242	CcSEcCtD
Liotrix—Hypokalaemia—Doxorubicin—bone cancer	0.000378	0.00239	CcSEcCtD
Liotrix—Angina pectoris—Epirubicin—bone cancer	0.000378	0.00239	CcSEcCtD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000377	0.00652	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000377	0.00652	CbGpPWpGaD
Liotrix—Decreased appetite—Cisplatin—bone cancer	0.000374	0.00236	CcSEcCtD
Liotrix—Bronchitis—Epirubicin—bone cancer	0.000373	0.00236	CcSEcCtD
Liotrix—SLC16A10—tendon—bone cancer	0.000369	0.0188	CbGeAlD
Liotrix—Muscular weakness—Doxorubicin—bone cancer	0.000366	0.00231	CcSEcCtD
Liotrix—Renal failure—Methotrexate—bone cancer	0.000363	0.00229	CcSEcCtD
Liotrix—Abdominal distension—Doxorubicin—bone cancer	0.000361	0.00228	CcSEcCtD
Liotrix—Dysphagia—Doxorubicin—bone cancer	0.000359	0.00227	CcSEcCtD
Liotrix—Sweating—Methotrexate—bone cancer	0.000354	0.00224	CcSEcCtD
Liotrix—Feeling abnormal—Cisplatin—bone cancer	0.000354	0.00223	CcSEcCtD
Liotrix—Weight decreased—Epirubicin—bone cancer	0.000351	0.00222	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—bone cancer	0.00035	0.00221	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—bone cancer	0.000345	0.00218	CcSEcCtD
Liotrix—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.00034	0.00588	CbGpPWpGaD
Liotrix—Renal failure—Epirubicin—bone cancer	0.00034	0.00215	CcSEcCtD
Liotrix—Body temperature increased—Cisplatin—bone cancer	0.00034	0.00214	CcSEcCtD
Liotrix—Sweating—Epirubicin—bone cancer	0.000332	0.00209	CcSEcCtD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000326	0.00563	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000326	0.00563	CbGpPWpGaD
Liotrix—Weight decreased—Doxorubicin—bone cancer	0.000325	0.00205	CcSEcCtD
Liotrix—TTR—Extracellular matrix organization—SPARC—bone cancer	0.000323	0.00558	CbGpPWpGaD
Liotrix—Hypersensitivity—Cisplatin—bone cancer	0.000317	0.002	CcSEcCtD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000316	0.00546	CbGpPWpGaD
Liotrix—Renal failure—Doxorubicin—bone cancer	0.000315	0.00199	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—bone cancer	0.000309	0.00195	CcSEcCtD
Liotrix—Asthenia—Cisplatin—bone cancer	0.000308	0.00195	CcSEcCtD
Liotrix—Sweating—Doxorubicin—bone cancer	0.000307	0.00194	CcSEcCtD
Liotrix—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000301	0.00521	CbGpPWpGaD
Liotrix—Diarrhoea—Cisplatin—bone cancer	0.000294	0.00186	CcSEcCtD
Liotrix—Alopecia—Methotrexate—bone cancer	0.000293	0.00185	CcSEcCtD
Liotrix—SLCO1A2—spinal cord—bone cancer	0.000291	0.0148	CbGeAlD
Liotrix—Flushing—Epirubicin—bone cancer	0.000288	0.00182	CcSEcCtD
Liotrix—THRB—Gene Expression—FUS—bone cancer	0.000287	0.00497	CbGpPWpGaD
Liotrix—THRA—Gene Expression—FUS—bone cancer	0.000287	0.00497	CbGpPWpGaD
Liotrix—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000287	0.00496	CbGpPWpGaD
Liotrix—Hypoaesthesia—Doxorubicin—bone cancer	0.000286	0.0018	CcSEcCtD
Liotrix—Dysgeusia—Methotrexate—bone cancer	0.000283	0.00179	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—bone cancer	0.000278	0.00175	CcSEcCtD
Liotrix—Alopecia—Epirubicin—bone cancer	0.000274	0.00173	CcSEcCtD
Liotrix—Vomiting—Cisplatin—bone cancer	0.000273	0.00172	CcSEcCtD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000273	0.00471	CbGpPWpGaD
Liotrix—Vision blurred—Methotrexate—bone cancer	0.000272	0.00172	CcSEcCtD
Liotrix—Rash—Cisplatin—bone cancer	0.000271	0.00171	CcSEcCtD
Liotrix—Dermatitis—Cisplatin—bone cancer	0.000271	0.00171	CcSEcCtD
Liotrix—Flushing—Doxorubicin—bone cancer	0.000267	0.00168	CcSEcCtD
Liotrix—Flatulence—Epirubicin—bone cancer	0.000266	0.00168	CcSEcCtD
Liotrix—Tension—Epirubicin—bone cancer	0.000265	0.00167	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—bone cancer	0.000265	0.00167	CcSEcCtD
Liotrix—Nervousness—Epirubicin—bone cancer	0.000263	0.00166	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—bone cancer	0.000257	0.00162	CcSEcCtD
Liotrix—Nausea—Cisplatin—bone cancer	0.000255	0.00161	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—bone cancer	0.000255	0.00161	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—bone cancer	0.000254	0.0016	CcSEcCtD
Liotrix—Convulsion—Methotrexate—bone cancer	0.00025	0.00158	CcSEcCtD
Liotrix—Agitation—Epirubicin—bone cancer	0.000248	0.00157	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—bone cancer	0.000247	0.00156	CcSEcCtD
Liotrix—Chest pain—Methotrexate—bone cancer	0.000246	0.00155	CcSEcCtD
Liotrix—Arthralgia—Methotrexate—bone cancer	0.000246	0.00155	CcSEcCtD
Liotrix—Tension—Doxorubicin—bone cancer	0.000246	0.00155	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—bone cancer	0.000245	0.00155	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—bone cancer	0.000243	0.00153	CcSEcCtD
Liotrix—Syncope—Epirubicin—bone cancer	0.000242	0.00153	CcSEcCtD
Liotrix—Palpitations—Epirubicin—bone cancer	0.000239	0.00151	CcSEcCtD
Liotrix—Confusional state—Methotrexate—bone cancer	0.000238	0.0015	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—bone cancer	0.000238	0.0015	CcSEcCtD
Liotrix—Anaphylactic shock—Methotrexate—bone cancer	0.000236	0.00149	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—bone cancer	0.000236	0.00149	CcSEcCtD
Liotrix—Convulsion—Epirubicin—bone cancer	0.000234	0.00148	CcSEcCtD
Liotrix—Infection—Methotrexate—bone cancer	0.000234	0.00148	CcSEcCtD
Liotrix—Hypertension—Epirubicin—bone cancer	0.000233	0.00147	CcSEcCtD
Liotrix—Chest pain—Epirubicin—bone cancer	0.00023	0.00145	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—bone cancer	0.00023	0.00145	CcSEcCtD
Liotrix—Agitation—Doxorubicin—bone cancer	0.00023	0.00145	CcSEcCtD
Liotrix—Anxiety—Epirubicin—bone cancer	0.000229	0.00145	CcSEcCtD
Liotrix—SLC16A10—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000229	0.00396	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—JUN—bone cancer	0.000229	0.00395	CbGpPWpGaD
Liotrix—Hyperhidrosis—Methotrexate—bone cancer	0.000228	0.00144	CcSEcCtD
Liotrix—ALB—Folate Metabolism—DHFR—bone cancer	0.000228	0.00393	CbGpPWpGaD
Liotrix—Anorexia—Methotrexate—bone cancer	0.000225	0.00142	CcSEcCtD
Liotrix—Syncope—Doxorubicin—bone cancer	0.000224	0.00142	CcSEcCtD
Liotrix—SLC10A1—Metabolism—NDUFA12—bone cancer	0.000223	0.00386	CbGpPWpGaD
Liotrix—Confusional state—Epirubicin—bone cancer	0.000223	0.0014	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—bone cancer	0.000221	0.0014	CcSEcCtD
Liotrix—Oedema—Epirubicin—bone cancer	0.000221	0.00139	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—bone cancer	0.000221	0.00139	CcSEcCtD
Liotrix—Hypotension—Methotrexate—bone cancer	0.00022	0.00139	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—bone cancer	0.00022	0.00139	CcSEcCtD
Liotrix—Infection—Epirubicin—bone cancer	0.000219	0.00138	CcSEcCtD
Liotrix—Shock—Epirubicin—bone cancer	0.000217	0.00137	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—bone cancer	0.000217	0.00137	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—bone cancer	0.000216	0.00136	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—bone cancer	0.000215	0.00136	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000215	0.00136	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—bone cancer	0.000213	0.00135	CcSEcCtD
Liotrix—Insomnia—Methotrexate—bone cancer	0.000213	0.00135	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—bone cancer	0.000213	0.00134	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—bone cancer	0.000213	0.00134	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—bone cancer	0.000212	0.00134	CcSEcCtD
Liotrix—Paraesthesia—Methotrexate—bone cancer	0.000212	0.00134	CcSEcCtD
Liotrix—Anorexia—Epirubicin—bone cancer	0.00021	0.00133	CcSEcCtD
Liotrix—Dyspnoea—Methotrexate—bone cancer	0.00021	0.00133	CcSEcCtD
Liotrix—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000209	0.00362	CbGpPWpGaD
Liotrix—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000207	0.00357	CbGpPWpGaD
Liotrix—Hypotension—Epirubicin—bone cancer	0.000206	0.0013	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—bone cancer	0.000206	0.0013	CcSEcCtD
Liotrix—Decreased appetite—Methotrexate—bone cancer	0.000205	0.00129	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—bone cancer	0.000204	0.00129	CcSEcCtD
Liotrix—Oedema—Doxorubicin—bone cancer	0.000204	0.00129	CcSEcCtD
Liotrix—Fatigue—Methotrexate—bone cancer	0.000203	0.00128	CcSEcCtD
Liotrix—Infection—Doxorubicin—bone cancer	0.000203	0.00128	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000201	0.00127	CcSEcCtD
Liotrix—Shock—Doxorubicin—bone cancer	0.000201	0.00127	CcSEcCtD
Liotrix—Insomnia—Epirubicin—bone cancer	0.0002	0.00126	CcSEcCtD
Liotrix—ALB—Platelet degranulation—SPARC—bone cancer	0.000199	0.00345	CbGpPWpGaD
Liotrix—Tachycardia—Doxorubicin—bone cancer	0.000199	0.00126	CcSEcCtD
Liotrix—THRB—Gene Expression—NR1I2—bone cancer	0.000199	0.00344	CbGpPWpGaD
Liotrix—THRA—Gene Expression—NR1I2—bone cancer	0.000199	0.00344	CbGpPWpGaD
Liotrix—Paraesthesia—Epirubicin—bone cancer	0.000198	0.00125	CcSEcCtD
Liotrix—SLC16A10—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000198	0.00342	CbGpPWpGaD
Liotrix—Hyperhidrosis—Doxorubicin—bone cancer	0.000197	0.00125	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—bone cancer	0.000197	0.00124	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—bone cancer	0.000195	0.00123	CcSEcCtD
Liotrix—Feeling abnormal—Methotrexate—bone cancer	0.000194	0.00123	CcSEcCtD
Liotrix—Gastrointestinal pain—Methotrexate—bone cancer	0.000193	0.00122	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—bone cancer	0.000192	0.00121	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—bone cancer	0.000191	0.0012	CcSEcCtD
Liotrix—Fatigue—Epirubicin—bone cancer	0.00019	0.0012	CcSEcCtD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00019	0.00328	CbGpPWpGaD
Liotrix—Constipation—Epirubicin—bone cancer	0.000189	0.00119	CcSEcCtD
Liotrix—Urticaria—Methotrexate—bone cancer	0.000187	0.00118	CcSEcCtD
Liotrix—Abdominal pain—Methotrexate—bone cancer	0.000186	0.00118	CcSEcCtD
Liotrix—Body temperature increased—Methotrexate—bone cancer	0.000186	0.00118	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000186	0.00117	CcSEcCtD
Liotrix—SLC10A1—Metabolism—NT5C3A—bone cancer	0.000185	0.0032	CbGpPWpGaD
Liotrix—Insomnia—Doxorubicin—bone cancer	0.000185	0.00117	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—bone cancer	0.000183	0.00116	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—bone cancer	0.000182	0.00115	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—bone cancer	0.000182	0.00115	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—bone cancer	0.00018	0.00114	CcSEcCtD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000179	0.00309	CbGpPWpGaD
Liotrix—Decreased appetite—Doxorubicin—bone cancer	0.000178	0.00112	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—bone cancer	0.000176	0.00111	CcSEcCtD
Liotrix—Urticaria—Epirubicin—bone cancer	0.000175	0.00111	CcSEcCtD
Liotrix—Constipation—Doxorubicin—bone cancer	0.000175	0.0011	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—bone cancer	0.000174	0.0011	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—bone cancer	0.000174	0.0011	CcSEcCtD
Liotrix—Hypersensitivity—Methotrexate—bone cancer	0.000174	0.0011	CcSEcCtD
Liotrix—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00017	0.00293	CbGpPWpGaD
Liotrix—Asthenia—Methotrexate—bone cancer	0.000169	0.00107	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—bone cancer	0.000168	0.00106	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—bone cancer	0.000167	0.00105	CcSEcCtD
Liotrix—Pruritus—Methotrexate—bone cancer	0.000167	0.00105	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—bone cancer	0.000163	0.00103	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—bone cancer	0.000162	0.00102	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—bone cancer	0.000161	0.00102	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—bone cancer	0.000161	0.00102	CcSEcCtD
Liotrix—Diarrhoea—Methotrexate—bone cancer	0.000161	0.00102	CcSEcCtD
Liotrix—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000158	0.00274	CbGpPWpGaD
Liotrix—Asthenia—Epirubicin—bone cancer	0.000158	0.000999	CcSEcCtD
Liotrix—Pruritus—Epirubicin—bone cancer	0.000156	0.000985	CcSEcCtD
Liotrix—Dizziness—Methotrexate—bone cancer	0.000156	0.000984	CcSEcCtD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000154	0.00267	CbGpPWpGaD
Liotrix—Diarrhoea—Epirubicin—bone cancer	0.000151	0.000953	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—bone cancer	0.00015	0.000949	CcSEcCtD
Liotrix—Vomiting—Methotrexate—bone cancer	0.00015	0.000946	CcSEcCtD
Liotrix—Rash—Methotrexate—bone cancer	0.000149	0.000938	CcSEcCtD
Liotrix—Dermatitis—Methotrexate—bone cancer	0.000149	0.000937	CcSEcCtD
Liotrix—Headache—Methotrexate—bone cancer	0.000148	0.000932	CcSEcCtD
Liotrix—THRB—Gene Expression—EIF2S1—bone cancer	0.000147	0.00254	CbGpPWpGaD
Liotrix—THRA—Gene Expression—EIF2S1—bone cancer	0.000147	0.00254	CbGpPWpGaD
Liotrix—Asthenia—Doxorubicin—bone cancer	0.000147	0.000925	CcSEcCtD
Liotrix—Dizziness—Epirubicin—bone cancer	0.000146	0.000921	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—bone cancer	0.000144	0.000912	CcSEcCtD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000141	0.00243	CbGpPWpGaD
Liotrix—Vomiting—Epirubicin—bone cancer	0.00014	0.000885	CcSEcCtD
Liotrix—Nausea—Methotrexate—bone cancer	0.00014	0.000884	CcSEcCtD
Liotrix—SLCO1B3—Metabolism—NDUFA12—bone cancer	0.00014	0.00242	CbGpPWpGaD
Liotrix—Diarrhoea—Doxorubicin—bone cancer	0.00014	0.000882	CcSEcCtD
Liotrix—Rash—Epirubicin—bone cancer	0.000139	0.000878	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—bone cancer	0.000139	0.000877	CcSEcCtD
Liotrix—TTR—Extracellular matrix organization—MMP2—bone cancer	0.000138	0.00239	CbGpPWpGaD
Liotrix—Headache—Epirubicin—bone cancer	0.000138	0.000872	CcSEcCtD
Liotrix—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000137	0.00236	CbGpPWpGaD
Liotrix—Dizziness—Doxorubicin—bone cancer	0.000135	0.000852	CcSEcCtD
Liotrix—Nausea—Epirubicin—bone cancer	0.000131	0.000827	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—bone cancer	0.00013	0.000819	CcSEcCtD
Liotrix—Rash—Doxorubicin—bone cancer	0.000129	0.000812	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—bone cancer	0.000129	0.000812	CcSEcCtD
Liotrix—Headache—Doxorubicin—bone cancer	0.000128	0.000807	CcSEcCtD
Liotrix—THRB—Gene Expression—EZH2—bone cancer	0.000128	0.00221	CbGpPWpGaD
Liotrix—THRA—Gene Expression—EZH2—bone cancer	0.000128	0.00221	CbGpPWpGaD
Liotrix—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000125	0.00216	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000121	0.0021	CbGpPWpGaD
Liotrix—Nausea—Doxorubicin—bone cancer	0.000121	0.000765	CcSEcCtD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00012	0.00208	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NT5C3A—bone cancer	0.000116	0.002	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.00011	0.0019	CbGpPWpGaD
Liotrix—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000107	0.00185	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RGS1—bone cancer	0.000106	0.00184	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—GRM4—bone cancer	0.000106	0.00184	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—MMP9—bone cancer	0.000104	0.0018	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000104	0.00179	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000102	0.00177	CbGpPWpGaD
Liotrix—TTR—Disease—ENO2—bone cancer	9.79e-05	0.00169	CbGpPWpGaD
Liotrix—ABCB1—bone marrow—bone cancer	9.78e-05	0.00498	CbGeAlD
Liotrix—ABCB1—spinal cord—bone cancer	9.74e-05	0.00496	CbGeAlD
Liotrix—SLCO1B1—Metabolism—NDUFA12—bone cancer	9.4e-05	0.00162	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—GRM1—bone cancer	9.23e-05	0.00159	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NT5C3A—bone cancer	9.11e-05	0.00157	CbGpPWpGaD
Liotrix—TTR—Disease—DHFR—bone cancer	9.08e-05	0.00157	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—CYP3A4—bone cancer	9.01e-05	0.00156	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	8.89e-05	0.00154	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	8.84e-05	0.00153	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	8.71e-05	0.0015	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ENO2—bone cancer	8.11e-05	0.0014	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	8.09e-05	0.0014	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.93e-05	0.00137	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NT5C3A—bone cancer	7.79e-05	0.00135	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—GSTP1—bone cancer	7.71e-05	0.00133	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.6e-05	0.00131	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—DHFR—bone cancer	7.52e-05	0.0013	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	7.33e-05	0.00127	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.22e-05	0.00125	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.12e-05	0.00123	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GNA11—bone cancer	7.03e-05	0.00122	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.87e-05	0.00119	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	6.79e-05	0.00117	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.75e-05	0.00117	CbGpPWpGaD
Liotrix—TTR—Disease—TGFBR2—bone cancer	6.58e-05	0.00114	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SMO—bone cancer	6.5e-05	0.00112	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CYP3A4—bone cancer	6.37e-05	0.0011	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.34e-05	0.0011	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.04e-05	0.00104	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.02e-05	0.00104	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—GNA11—bone cancer	5.95e-05	0.00103	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.93e-05	0.00102	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ATF1—bone cancer	5.53e-05	0.000955	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GSTP1—bone cancer	5.45e-05	0.000942	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NDUFA12—bone cancer	5.4e-05	0.000934	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL3—bone cancer	5.39e-05	0.000932	CbGpPWpGaD
Liotrix—ALB—Metabolism—NDUFA12—bone cancer	5.37e-05	0.000928	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.2e-05	0.000898	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TP53—bone cancer	5.08e-05	0.000879	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ENO2—bone cancer	5.08e-05	0.000878	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—DHFR—bone cancer	4.71e-05	0.000814	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NDUFA12—bone cancer	4.71e-05	0.000813	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFBR2—bone cancer	4.61e-05	0.000797	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SPARC—bone cancer	4.56e-05	0.000788	CbGpPWpGaD
Liotrix—TTR—Disease—KIT—bone cancer	4.49e-05	0.000776	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.48e-05	0.000774	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NT5C3A—bone cancer	4.48e-05	0.000774	CbGpPWpGaD
Liotrix—ALB—Metabolism—NT5C3A—bone cancer	4.45e-05	0.000769	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GNA11—bone cancer	4.4e-05	0.000761	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IGF1R—bone cancer	4.34e-05	0.00075	CbGpPWpGaD
Liotrix—TTR—Disease—BRAF—bone cancer	4.22e-05	0.00073	CbGpPWpGaD
Liotrix—ALB—Hemostasis—GNA11—bone cancer	4.17e-05	0.00072	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP3A4—bone cancer	3.99e-05	0.00069	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ENO2—bone cancer	3.99e-05	0.00069	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.97e-05	0.000686	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NT5C3A—bone cancer	3.9e-05	0.000674	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL3—bone cancer	3.78e-05	0.000653	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—DHFR—bone cancer	3.7e-05	0.00064	CbGpPWpGaD
Liotrix—TTR—Disease—MDM2—bone cancer	3.54e-05	0.000611	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GNA11—bone cancer	3.46e-05	0.000598	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTP1—bone cancer	3.41e-05	0.00059	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ENO2—bone cancer	3.41e-05	0.00059	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—bone cancer	3.41e-05	0.000589	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.32e-05	0.000573	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.2e-05	0.000553	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—DHFR—bone cancer	3.17e-05	0.000547	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KIT—bone cancer	3.15e-05	0.000544	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP3A4—bone cancer	3.14e-05	0.000542	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.12e-05	0.000539	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GNA11—bone cancer	2.96e-05	0.000511	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—BRAF—bone cancer	2.96e-05	0.000511	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.88e-05	0.000498	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—bone cancer	2.82e-05	0.000488	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTP1—bone cancer	2.68e-05	0.000464	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP3A4—bone cancer	2.68e-05	0.000464	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.67e-05	0.000461	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAU—bone cancer	2.48e-05	0.000428	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MDM2—bone cancer	2.48e-05	0.000428	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—bone cancer	2.42e-05	0.000418	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTP1—bone cancer	2.29e-05	0.000396	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.27e-05	0.000392	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—JUN—bone cancer	2.15e-05	0.000372	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—bone cancer	2.1e-05	0.000362	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ENO2—bone cancer	1.96e-05	0.000339	CbGpPWpGaD
Liotrix—ALB—Metabolism—ENO2—bone cancer	1.95e-05	0.000337	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.9e-05	0.000329	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—DHFR—bone cancer	1.82e-05	0.000314	CbGpPWpGaD
Liotrix—ALB—Metabolism—DHFR—bone cancer	1.81e-05	0.000313	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—bone cancer	1.77e-05	0.000306	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ENO2—bone cancer	1.71e-05	0.000295	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GNA11—bone cancer	1.7e-05	0.000294	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—bone cancer	1.69e-05	0.000293	CbGpPWpGaD
Liotrix—ALB—Metabolism—GNA11—bone cancer	1.69e-05	0.000292	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—DHFR—bone cancer	1.58e-05	0.000274	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP3A4—bone cancer	1.54e-05	0.000266	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.53e-05	0.000265	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP3A4—bone cancer	1.53e-05	0.000265	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.52e-05	0.000263	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GNA11—bone cancer	1.48e-05	0.000256	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—bone cancer	1.42e-05	0.000246	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—bone cancer	1.39e-05	0.00024	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP3A4—bone cancer	1.34e-05	0.000232	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—bone cancer	1.32e-05	0.000228	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—bone cancer	1.31e-05	0.000226	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—bone cancer	1.19e-05	0.000205	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—bone cancer	1.15e-05	0.000198	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—bone cancer	9.97e-06	0.000172	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—bone cancer	6.83e-06	0.000118	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—bone cancer	6.79e-06	0.000117	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—bone cancer	5.95e-06	0.000103	CbGpPWpGaD
